2Adams HP Jr, Brott TG, Crowell RM, et al. Guidelines for the management of patients with acute ischemic stroke: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Circulation, 1994, 90:1588 -1601.
3Adams HP Jr, Adams RJ, Brott T, et al. Guidelines for the early management of patents with ischemic stroke: a scientific statement from the Stroke Council of the American Stroke Association, Stroke, 2003,34:1056 - 1083.
4Adams RJ, Chimowitz MI, Alpert JS, et al. Coronary risk evaluation in patients with transient ischemic attack and ischemic stroke: a scientific statement for heakhcare professionals from the Stroke Council and the Council on Clinical Cardiology of the American Heart Association/American Stroke Association. Circulation, 2003, 108:1278 -19ON.
1[2]Tanne D, Kasner SE, Demchuk AM, et al. Markers of in creased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemia stroke in clinical practice :the multicenter rt-PA Stroke Survey [J].Circulation,2002,105 (14):1679- 1685.
2[4]Wholey MH, Wholey MH, Tan WA,et al. A comparison of balloon-mounted and self-expanding stents in the carotid arteries: immediate and long-term results of more than 500 patients [J]. J Endovasc Ther,2003,10(2):171- 181.
3[5]Lenhart M, Framme N, Volk M, et al.Time-resolved con trast-enhanced magnetic resonance angiography of the carotid arteries: diagnostic accuracy and inter-observer variability compared with selective catheter angiography[J]. Invest Radiol, 2002,37(10):535-541.
